Stephen  Ethier  to  Gene Expression Profiling
                            
                            
                                This is a "connection" page, showing publications  Stephen  Ethier  has written about  Gene Expression Profiling.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.450
         
        
        
     
 
    
        
        - 
            KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
            
            
                Score: 0.096
             
- 
            Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 2010 Nov 01; 70(21):8487-97.
            
            
                Score: 0.073
             
- 
            Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2010 May; 121(1):53-64.
            
            
                Score: 0.067
             
- 
            Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene. 2007 Mar 29; 26(14):2104-14.
            
            
                Score: 0.055
             
- 
            Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001 Jul 01; 61(13):5168-78.
            
            
                Score: 0.039
             
- 
            Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000 Aug 15; 60(16):4519-25.
            
            
                Score: 0.036
             
- 
            Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016 10 11; 7:13050.
            
            
                Score: 0.028
             
- 
            Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013 Oct 14; 24(4):450-65.
            
            
                Score: 0.023
             
- 
            Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011 Feb 15; 71(4):1292-301.
            
            
                Score: 0.019
             
- 
            A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006 Dec; 10(6):515-27.
            
            
                Score: 0.014